222 related articles for article (PubMed ID: 17707776)
1. Transgenic mice with neuron-specific overexpression of HtrA2/Omi suggest a neuroprotective role for HtrA2/Omi.
Liu MJ; Liu ML; Shen YF; Kim JM; Lee BH; Lee YS; Hong ST
Biochem Biophys Res Commun; 2007 Oct; 362(2):295-300. PubMed ID: 17707776
[TBL] [Abstract][Full Text] [Related]
2. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.
Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A
Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
[TBL] [Abstract][Full Text] [Related]
4. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.
Liu HR; Gao E; Hu A; Tao L; Qu Y; Most P; Koch WJ; Christopher TA; Lopez BL; Alnemri ES; Zervos AS; Ma XL
Circulation; 2005 Jan; 111(1):90-6. PubMed ID: 15611365
[TBL] [Abstract][Full Text] [Related]
5. Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta.
Liu ML; Liu MJ; Shen YF; Ryu H; Kim HJ; Klupsch K; Downward J; Hong ST
J Cell Sci; 2009 Jun; 122(Pt 11):1917-26. PubMed ID: 19435805
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal.
Vande Walle L; Wirawan E; Lamkanfi M; Festjens N; Verspurten J; Saelens X; Vanden Berghe T; Vandenabeele P
Cell Res; 2010 Apr; 20(4):421-33. PubMed ID: 20125124
[TBL] [Abstract][Full Text] [Related]
7. Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease.
Inagaki R; Tagawa K; Qi ML; Enokido Y; Ito H; Tamura T; Shimizu S; Oyanagi K; Arai N; Kanazawa I; Wanker EE; Okazawa H
Eur J Neurosci; 2008 Jul; 28(1):30-40. PubMed ID: 18662332
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
9. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice.
Jones JM; Datta P; Srinivasula SM; Ji W; Gupta S; Zhang Z; Davies E; Hajnóczky G; Saunders TL; Van Keuren ML; Fernandes-Alnemri T; Meisler MH; Alnemri ES
Nature; 2003 Oct; 425(6959):721-7. PubMed ID: 14534547
[TBL] [Abstract][Full Text] [Related]
10. Proteome-wide Identification of HtrA2/Omi Substrates.
Vande Walle L; Van Damme P; Lamkanfi M; Saelens X; Vandekerckhove J; Gevaert K; Vandenabeele P
J Proteome Res; 2007 Mar; 6(3):1006-15. PubMed ID: 17266347
[TBL] [Abstract][Full Text] [Related]
11. Association of Omi/HtrA2 with γ-secretase in mitochondria.
Behbahani H; Pavlov PF; Wiehager B; Nishimura T; Winblad B; Ankarcrona M
Neurochem Int; 2010 Nov; 57(6):668-75. PubMed ID: 20705111
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1.
Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
Brain Res Mol Brain Res; 2004 Aug; 127(1-2):89-95. PubMed ID: 15306124
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Omi/HtrA2 on expression of anti-apoptotic protein PED/PEA-15 and apoptosis of prostate cancer cell line PC-3].
Hu XY; Chen XC; Zhu ZH; Chen CH; Zeng FQ; Lu GC
Ai Zheng; 2006 Jun; 25(6):677-82. PubMed ID: 16764760
[TBL] [Abstract][Full Text] [Related]
15. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity.
van Loo G; van Gurp M; Depuydt B; Srinivasula SM; Rodriguez I; Alnemri ES; Gevaert K; Vandekerckhove J; Declercq W; Vandenabeele P
Cell Death Differ; 2002 Jan; 9(1):20-6. PubMed ID: 11803371
[TBL] [Abstract][Full Text] [Related]
16. Specific protein interaction of human Pag with Omi/HtrA2 and the activation of the protease activity of Omi/HtrA2.
Hong SK; Cha MK; Kim IH
Free Radic Biol Med; 2006 Jan; 40(2):275-84. PubMed ID: 16413409
[TBL] [Abstract][Full Text] [Related]
17. The mitochondrial serine protease HtrA2/Omi: an overview.
Vande Walle L; Lamkanfi M; Vandenabeele P
Cell Death Differ; 2008 Mar; 15(3):453-60. PubMed ID: 18174901
[TBL] [Abstract][Full Text] [Related]
18. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration.
Ding X; Patel M; Shen D; Herzlich AA; Cao X; Villasmil R; Klupsch K; Tuo J; Downward J; Chan CC
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4957-66. PubMed ID: 19443712
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death.
Kuninaka S; Nomura M; Hirota T; Iida S; Hara T; Honda S; Kunitoku N; Sasayama T; Arima Y; Marumoto T; Koja K; Yonehara S; Saya H
Oncogene; 2005 Aug; 24(34):5287-98. PubMed ID: 16007220
[TBL] [Abstract][Full Text] [Related]
20. Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level.
Xu Z; Chen Y; Xu G; Peng C; Liu E; Li Y; Niu J; Li C
Oncol Rep; 2015 Feb; 33(2):905-12. PubMed ID: 25484138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
